Abstract:HomeCirculation: Arrhythmia and ElectrophysiologyVol. 16, No. 1Characteristics of Patients with Spontaneous Versus Drug-Induced Brugada Electrocardiogram: Sub-Analysis From the SABRUS Free AccessLetterPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessLetterPDF/EPUBCharacteristics of Patients with Spontaneous Versus Drug-Induced Brugada Electrocardiogram: Sub-Analysis From the SABRUS Anat Milman, Avi Sabbag, Giulio Conte, Pieter G. Postema, Antoine Andorin, Jean-Baptiste Gourraud, Frederic Sacher, Philippe Mabo, Sung-Hwan Kim, Shingo Maeda, Yoshihide Takahashi, Tsukasa Kamakura, Takeshi Aiba, Jimmy JM Juang, Yoav Michowitz, Eran Leshem, Yuka Mizusawa, Elena Arbelo, Zhengrong Huang, Isabelle Denjoy, Carla Giustetto, Yanushi D. Wijeyeratne, Andrea Mazzanti, Ramon Brugada, Ruben Casado-Arroyo, Jean Champagne, Leonardo Calo, Georgia Sarquella-Brugada, Jacob Tfelt-Hansen, Silvia G. Priori, Masahiko Takagi, Christian Veltmann, Pietro Delise, Domenico Corrado, Elijah R. Behr, Fiorenzo Gaita, Gan-Xin Yan, Josep Brugada, Antoine Leenhardt, Arthur A.M. Wilde, Pedro Brugada, Kengo F. Kusano, Kenzo Hirao, Gi-Byoung Nam, Vincent Probst and Bernard Belhassen Anat MilmanAnat Milman Correspondence to: Anat Milman, MD PhD, Davidai Arrhythmia Center, Leviev Heart Center Sheba Medical Center, Tel Hashomer 5265601, Israel. Email E-mail Address: [email protected] https://orcid.org/0000-0002-8551-4101 Leviev Heart Institute, The Chaim Sheba Medical Centre, Tel Hashomer and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel (A.M., A.S., E.L.). Search for more papers by this author , Avi SabbagAvi Sabbag https://orcid.org/0000-0003-4295-6679 Leviev Heart Institute, The Chaim Sheba Medical Centre, Tel Hashomer and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel (A.M., A.S., E.L.). Search for more papers by this author , Giulio ConteGiulio Conte https://orcid.org/0000-0003-2248-3456 Heart Rhythm Management Centre, UZ-VUB, Brussels, Belgium (G.C., P.B.). Search for more papers by this author , Pieter G. PostemaPieter G. Postema https://orcid.org/0000-0003-2863-9159 European Reference Network for Rare & Low Prevalence Complex Diseases of the Heart (P.G.P., A.A., J.B.G., Y.M., E.A., Y.D.W., A.M., J.T.-H., S.G.P., D.C., E.R.B., F.G., A.A.M.W., V.P.). Amsterdam UMC, University of Amsterdam, Heart Centre and Department of Clinical and Experimental Cardiology, Amsterdam, the Netherlands (P.G.P., Y.M., A.A.M.W.). Search for more papers by this author , Antoine AndorinAntoine Andorin https://orcid.org/0000-0001-6848-5452 European Reference Network for Rare & Low Prevalence Complex Diseases of the Heart (P.G.P., A.A., J.B.G., Y.M., E.A., Y.D.W., A.M., J.T.-H., S.G.P., D.C., E.R.B., F.G., A.A.M.W., V.P.). Service de Cardiologie, CHU de Nantes (A.A., J.B.G., V.P.). Search for more papers by this author , Jean-Baptiste GourraudJean-Baptiste Gourraud https://orcid.org/0000-0002-6961-2131 European Reference Network for Rare & Low Prevalence Complex Diseases of the Heart (P.G.P., A.A., J.B.G., Y.M., E.A., Y.D.W., A.M., J.T.-H., S.G.P., D.C., E.R.B., F.G., A.A.M.W., V.P.). Service de Cardiologie, CHU de Nantes (A.A., J.B.G., V.P.). Search for more papers by this author , Frederic SacherFrederic Sacher https://orcid.org/0000-0001-8348-9320 Hôpital Cardiologique du Haut-Lévêque and University Bordeaux, LIRYC Instituteitute (F.S.). Search for more papers by this author , Philippe MaboPhilippe Mabo Cardiology and Vascular Disease Division, Rennes University Health Centre, Rennes, France (P.M.). Search for more papers by this author , Sung-Hwan KimSung-Hwan Kim https://orcid.org/0000-0001-6805-0416 Division of Cardiology, College of Medicine, The Catholic University of Korea, Seoul, Korea (S.-H.K.). Search for more papers by this author , Shingo MaedaShingo Maeda https://orcid.org/0000-0001-6964-0653 Heart Rhythm Centre, Tokyo Medical and Dental University, Tokyo (S.M., Y.T., K.H.). Search for more papers by this author , Yoshihide TakahashiYoshihide Takahashi https://orcid.org/0000-0003-0335-996X Heart Rhythm Centre, Tokyo Medical and Dental University, Tokyo (S.M., Y.T., K.H.). Search for more papers by this author , Tsukasa KamakuraTsukasa Kamakura https://orcid.org/0000-0003-2964-2544 Division of Arrhythmia & EleCentreophysiology, National Cerebral & Cardiovascular Centre, Osaka, Japan (T.K., T.A.). Search for more papers by this author , Takeshi AibaTakeshi Aiba https://orcid.org/0000-0003-1779-7282 Division of Arrhythmia & EleCentreophysiology, National Cerebral & Cardiovascular Centre, Osaka, Japan (T.K., T.A.). Search for more papers by this author , Jimmy JM JuangJimmy JM Juang https://orcid.org/0000-0003-4767-7636 Cardiovascular Centre and Division of Cardiology, National Taiwan University Hospital and University College of Medicine, Taipei, Taiwan (J.J.M.J.). Search for more papers by this author , Yoav MichowitzYoav Michowitz https://orcid.org/0000-0002-5665-3735 European Reference Network for Rare & Low Prevalence Complex Diseases of the Heart (P.G.P., A.A., J.B.G., Y.M., E.A., Y.D.W., A.M., J.T.-H., S.G.P., D.C., E.R.B., F.G., A.A.M.W., V.P.). Cardiology Department, Shaare Zedek Hospital, Affiliated to the Faculty of Medicine, Hebrew University, Jerusalem, Israel (Y.M.). Search for more papers by this author , Eran LeshemEran Leshem https://orcid.org/0000-0002-8896-460X Leviev Heart Institute, The Chaim Sheba Medical Centre, Tel Hashomer and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel (A.M., A.S., E.L.). Search for more papers by this author , Yuka MizusawaYuka Mizusawa https://orcid.org/0000-0003-1858-0923 Amsterdam UMC, University of Amsterdam, Heart Centre and Department of Clinical and Experimental Cardiology, Amsterdam, the Netherlands (P.G.P., Y.M., A.A.M.W.). Search for more papers by this author , Elena ArbeloElena Arbelo https://orcid.org/0000-0003-0424-6393 European Reference Network for Rare & Low Prevalence Complex Diseases of the Heart (P.G.P., A.A., J.B.G., Y.M., E.A., Y.D.W., A.M., J.T.-H., S.G.P., D.C., E.R.B., F.G., A.A.M.W., V.P.). Arrhythmia Section, Cardiology Department, Hospital Clínic, Universityersitat de Barcelona and bIDIBAPS, Instituteitut d’Investigació August Pi i Sunyer (IDIBAPS), Barcelona (E.A.). Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain (E.A.). Search for more papers by this author , Zhengrong HuangZhengrong Huang https://orcid.org/0000-0003-0007-9321 Department of Cardiology, the First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China (Z.H.). Search for more papers by this author , Isabelle DenjoyIsabelle Denjoy https://orcid.org/0000-0002-1786-9461 Service de Cardiologie et CNMR Maladies Cardiaques Héréditaires Rares, Hôpital Bichat, Paris and Université Paris Diderot, Sorbonne, France (I.D.). Search for more papers by this author , Carla GiustettoCarla Giustetto https://orcid.org/0000-0002-5102-3398 Division of Cardiology, Department of Medical Sciences, Città della Salute e della Scienza Hospital, University of Torino, Italy (C.G., F.G.). Search for more papers by this author , Yanushi D. WijeyeratneYanushi D. Wijeyeratne https://orcid.org/0000-0003-0656-5769 European Reference Network for Rare & Low Prevalence Complex Diseases of the Heart (P.G.P., A.A., J.B.G., Y.M., E.A., Y.D.W., A.M., J.T.-H., S.G.P., D.C., E.R.B., F.G., A.A.M.W., V.P.). Cardiovascular Sciences, St. George’s University of London and Cardiology Clinical Academic Group St. George’s University Hospitals NHS Foundation Trust, London, UK (Y.D.W., E.R.B.). Search for more papers by this author , Andrea MazzantiAndrea Mazzanti https://orcid.org/0000-0002-0208-2172 European Reference Network for Rare & Low Prevalence Complex Diseases of the Heart (P.G.P., A.A., J.B.G., Y.M., E.A., Y.D.W., A.M., J.T.-H., S.G.P., D.C., E.R.B., F.G., A.A.M.W., V.P.). Molecular Cardiology, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy (A.M.). Search for more papers by this author , Ramon BrugadaRamon Brugada https://orcid.org/0000-0001-6607-3032 Cardiovascular Genetics Center, University of Girona-IDIBGI and Medical Science Department, School of Medicine, University of Girona, Spain (R.B.). Search for more papers by this author , Ruben Casado-ArroyoRuben Casado-Arroyo Department of Cardiology, Erasme University Hospital, Universityersité Libre de Bruxelles, Belgium (R.C.-A.). Search for more papers by this author , Jean ChampagneJean Champagne https://orcid.org/0000-0001-9861-9351 Quebec Heart & Lung Institute, Quebec City, Canada (J.C.). Search for more papers by this author , Leonardo CaloLeonardo Calo https://orcid.org/0000-0002-6062-5286 Division of Cardiology, Policlinico Casilino, Roma, Italy (L.C.). Search for more papers by this author , Georgia Sarquella-BrugadaGeorgia Sarquella-Brugada https://orcid.org/0000-0002-6857-8904 Pediatric Arrhythmias, EleCentreophysiology and Sudden Death Unit Cardiology, Department Hospital Sant Joan de Déu, Barcelona - Universityersitat de Barcelona, Spain (G.S.-B.). Search for more papers by this author , Jacob Tfelt-HansenJacob Tfelt-Hansen European Reference Network for Rare & Low Prevalence Complex Diseases of the Heart (P.G.P., A.A., J.B.G., Y.M., E.A., Y.D.W., A.M., J.T.-H., S.G.P., D.C., E.R.B., F.G., A.A.M.W., V.P.). The Heart Centre, Copenhagen University Hospital and Department of Forensic Medicine, Faculty of Medical Sciences, University of Copenhagen, Denmark (J.T.-H.). Search for more papers by this author , Silvia G. PrioriSilvia G. Priori https://orcid.org/0000-0001-6877-0288 European Reference Network for Rare & Low Prevalence Complex Diseases of the Heart (P.G.P., A.A., J.B.G., Y.M., E.A., Y.D.W., A.M., J.T.-H., S.G.P., D.C., E.R.B., F.G., A.A.M.W., V.P.). Search for more papers by this author , Masahiko TakagiMasahiko Takagi https://orcid.org/0000-0001-7712-8529 Division of Cardiac Arrhythmia, Kansai Medical University Medical Centre, Moriguchi, Japan (M.T.). Search for more papers by this author , Christian VeltmannChristian Veltmann https://orcid.org/0000-0001-7587-1124 Hannover Heart Rhythm Centre, Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany (C.V.). Search for more papers by this author , Pietro DelisePietro Delise https://orcid.org/0000-0001-7190-4830 Division of Cardiology, Hospital of Peschiera del Garda, Veneto (P.D.). Search for more papers by this author , Domenico CorradoDomenico Corrado https://orcid.org/0000-0003-1487-0392 European Reference Network for Rare & Low Prevalence Complex Diseases of the Heart (P.G.P., A.A., J.B.G., Y.M., E.A., Y.D.W., A.M., J.T.-H., S.G.P., D.C., E.R.B., F.G., A.A.M.W., V.P.). Department of Cardiac, Thoracic & Vascular Sciences University of Padova, Italy (D.C.). Search for more papers by this author , Elijah R. BehrElijah R. Behr https://orcid.org/0000-0002-8731-2853 European Reference Network for Rare & Low Prevalence Complex Diseases of the Heart (P.G.P., A.A., J.B.G., Y.M., E.A., Y.D.W., A.M., J.T.-H., S.G.P., D.C., E.R.B., F.G., A.A.M.W., V.P.). Cardiovascular Sciences, St. George’s University of London and Cardiology Clinical Academic Group St. George’s University Hospitals NHS Foundation Trust, London, UK (Y.D.W., E.R.B.). Search for more papers by this author , Fiorenzo GaitaFiorenzo Gaita European Reference Network for Rare & Low Prevalence Complex Diseases of the Heart (P.G.P., A.A., J.B.G., Y.M., E.A., Y.D.W., A.M., J.T.-H., S.G.P., D.C., E.R.B., F.G., A.A.M.W., V.P.). Division of Cardiology, Department of Medical Sciences, Città della Salute e della Scienza Hospital, University of Torino, Italy (C.G., F.G.). Search for more papers by this author , Gan-Xin YanGan-Xin Yan https://orcid.org/0000-0002-3118-5680 Lankenau Medical Centre, Wynnewood, PA (G.X.Y.). Search for more papers by this author , Josep BrugadaJosep Brugada https://orcid.org/0000-0002-5662-8302 Search for more papers by this author , Antoine LeenhardtAntoine Leenhardt https://orcid.org/0000-0001-7368-4528 Search for more papers by this author , Arthur A.M. WildeArthur A.M. Wilde https://orcid.org/0000-0002-0528-0852 European Reference Network for Rare & Low Prevalence Complex Diseases of the Heart (P.G.P., A.A., J.B.G., Y.M., E.A., Y.D.W., A.M., J.T.-H., S.G.P., D.C., E.R.B., F.G., A.A.M.W., V.P.). Amsterdam UMC, University of Amsterdam, Heart Centre and Department of Clinical and Experimental Cardiology, Amsterdam, the Netherlands (P.G.P., Y.M., A.A.M.W.). Search for more papers by this author , Pedro BrugadaPedro Brugada https://orcid.org/0000-0003-3172-6106 Heart Rhythm Management Centre, UZ-VUB, Brussels, Belgium (G.C., P.B.). Search for more papers by this author , Kengo F. KusanoKengo F. Kusano Search for more papers by this author , Kenzo HiraoKenzo Hirao Heart Rhythm Centre, Tokyo Medical and Dental University, Tokyo (S.M., Y.T., K.H.). Search for more papers by this author , Gi-Byoung NamGi-Byoung Nam https://orcid.org/0000-0003-4391-5406 Division of Cardiology, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, Korea (Gi-Byoung Nam). Search for more papers by this author , Vincent ProbstVincent Probst https://orcid.org/0000-0002-5492-8619 European Reference Network for Rare & Low Prevalence Complex Diseases of the Heart (P.G.P., A.A., J.B.G., Y.M., E.A., Y.D.W., A.M., J.T.-H., S.G.P., D.C., E.R.B., F.G., A.A.M.W., V.P.). Service de Cardiologie, CHU de Nantes (A.A., J.B.G., V.P.). Search for more papers by this author and Bernard BelhassenBernard Belhassen https://orcid.org/0000-0002-7468-2054 Heart Institute, Hadassah University Hospital, Jerusalem, Israel (B.B.) Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel (B.B.). Search for more papers by this author Originally published3 Jan 2023https://doi.org/10.1161/CIRCEP.122.011360Circulation: Arrhythmia and Electrophysiology. 2023;16Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: January 3, 2023: Ahead of Print Patients with Brugada syndrome (BrS) may display either a spontaneous (S) or a drug-induced (DI) ECG pattern. The latter group is considered at a lower risk of arrhythmic events (AE) and sudden cardiac death (SCD). The only study that compared these 2 groups in BrS associated with AEs comprised a small cohort of 44 patients.1The SABRUS study (Survey on Arrhythmic events in Brugada Syndrome) gathers the largest cohort of patients with BrS and AEs published to date.2 The data that support the findings of this study are available from the corresponding author upon reasonable request. Patients were divided into 2 groups according to their AE presentation: group A presented with aborted cardiac arrest before diagnosis of BrS and group B were Brugada patients implanted prophylactically with an ICD, which proved to be justified during follow-up. The present study compares DI-BrS and S-BrS patients from SABRUS. The study was approved by the Institutional Committee on Human Research at the Tel Aviv Sourasky Medical Center. Continuous variables are presented as mean±SD or median (interquartile range) and compared using the student t test or Mann-Whitney U test as appropriate. Categorical variables are presented by absolute numbers and proportions and compared using the χ2 test or Fisher exact test. All tests were 2-tailed, and a P<0.05 was considered statistically significant.Of the 678 SABRUS patients, 451 (66.5%) had S-BrS ECG and 227 (33.5%) had DI-BrS ECG (Table 1). Females predominated in the DI-ECG group (15.4% versus 5.3% in the S-ECG group, P<0.001), with less Asians than Whites (33.9% versus 42.8% in the S-ECG group, P=0.036). Higher inducibility rates of ventricular fibrillation (VF) at electrophysiologic study (EPS) were found in the S-ECG group (67.3% versus 55%.7 in the DI-ECG groups, respectively, P=0.022), with a similar rate of EPS performed in both groups (61.7% in the DI-ECG group versus 57.6% in the S-ECG group, P=0.315). There were no differences between DI-BrS ECG and S-BrS ECG patients regarding age at AE, proband status, history of syncope, AE presentation, family history of sudden cardiac death, fever-related events, and genetic analysis.Table 1. Patient Characteristics According to Brugada ECG TypeDrug-Induced BrECGSpontaneous BrECGPn=227 (33.5%)n=451 (66.5%)Age at AE, y (mean±SD)42±1442±150.969 Age at AE ≤169 (4)23 (5.1)0.532 Age at AE >16218 (96)428 (94.9)Gender Men192 (84.6)427 (94.7)<0.001 Women35 (15.4)24 (5.3)Ethnicity White130 (57.3)234 (51.9)0.036 Asian77 (33.9)193 (42.8) Other/unknown20 (8.8)24 (5.3)Arrhythmic event documentation Group A150 (66.1)276 (61.2)0.214 Group B77 (33.9)175 (38.8)Proband status181 (85.4)361 (86.4)0.736History of syncope82 (36.1)183 (40.6)0.262Fever during AE11 (5.9)24 (6)0.961Family history of SCD Yes46 (20.3)99 (22)0.851 No158 (69.6)310 (68.7) Unknown23 (10.1)42 (9.3)EPS performed140 (61.7)260 (57.6)0.315VF inducibility during EPS78 (55.7)175 (67.3)0.022Genetic analysis performed158 (69.6)327 (72.5)0.429SCN5A mutation present41 (25.9)102 (31.2)0.235AE indicates arrhythmic event; BrECG, Brugada electrocardiogram; EPS, electrophysiologic study; SCD, sudden cardiac death; and VF, ventricular fibrillation.To the best of our knowledge, this is the first study comparing BrS patients with S-ECG and DI-ECG in a large population cohort with AEs. Although a previous article by Tadros et al3 showed that 8% of patients tested by drug provocation for BrS could have false positive results, we assume, based on our findings of the SABRUS cohort,4 that all our patients with DI-ECG have proven BrS, and that the results of our study should be taken in this context only.Syncope combined with a spontaneous type 1 Brugada ECG has been shown to be useful for identifying Brugada patients at risk for AE. However, this is not relevant when a DI-ECG is encountered. In addition, the use of programmed ventricular stimulation has shown conflicting results. In a large series of patients with DI-BrS ECG, Sieira et al5 showed that VF inducibility rate was significantly lower than in patients with S-BrS ECG (13.2% versus 42.4%, respectively, P<0.01); however their cohort comprised a minority of patients with AEs. In our cohort comprising only patients with AEs, the lower inducibility rate is confirmed (55.7% versus 67.3%, respectively, P=0.022). These findings suggest that EPS is less useful for the management of BrS patients with DI-ECG, and do not inform necessarily on risk stratification strategies. These findings could actually represent a difference in the mechanism of arrhythmia generation of the 2 subgroups of Brugada patients, and future studies should test whether this could explain the lower arrhythmic risk of DI-ECG patients.Females predominated in our DI-ECG group. This is in line with the study by Nagayama et al1 in a smaller cohort.For the first time, SABRUS showed that Asians with AEs displayed significantly less DI-ECG compared with whites. This may suggest that a genetic predisposition of Asians plays a role in the occurrence of the S-BrS ECG type.No difference in the presence of SCN5A gene mutation was found between the DI-ECG and S-ECG groups. These findings agree with those reported by Nagayama et al1 in a similar, although significantly smaller patient cohort.In conclusion, DI-BrS patients represented a third of BrS cohort with AEs. They differed from S-BrS patients in gender, ethnicity, and VF inducibility rates. The most important observation is that this group of patients is less studied, and identifying high-risk DI-BrS patients is not an easy task. We encourage seeking new risk markers in this group in future studies.Article InformationSources of FundingNone.Nonstandard Abbreviations and AcronymsAEarrhythmic eventsBrSBrugada syndromeDIdrug-inducedICDimplantable cardiac defibrillatorSspontaneousSABRUSSurvey on Arrhythmic events in Brugada SyndromeVFventricular fibrillationDisclosures None.FootnotesFor Sources of Funding and Disclosures, see page 64.Correspondence to: Anat Milman, MD PhD, Davidai Arrhythmia Center, Leviev Heart Center Sheba Medical Center, Tel Hashomer 5265601, Israel. Email anatmilman@gmail.comReferences1. Nagayama T, Nagase S, Kamakura T, Wada M, Ishibashi K, Inoue YY, Miyamoto K, Noda T, Aiba T, Takaki HT, et al. Clinical and electrocardiographic differences in Brugada syndrome with spontaneous or drug-induced type 1 electrocardiogram.Circ J. 2019; 83:532–539. doi: 10.1253/circj.cj-18-0643CrossrefMedlineGoogle Scholar2. Milman A, Gourraud JB, Andorin A, Postema PG, Sacher F, Mabo P, Conte G, Giustetto C, Sarquella-Brugada G, Hochstadt A, et al. Gender differences in patients with Brugada syndrome and arrhythmic events: data from a survey on arrhythmic events in 678 patients.Heart Rhythm. 2018; 15:1457–1465. doi: 10.1016/j.hrthm.2018.06.019CrossrefMedlineGoogle Scholar3. Tadros R, Nannenberg EA, Lieve KV, Škorić-Milosavljević D, Lahrouchi N, Lekanne Deprez RH, Vendrik J, Reckman YJ, Postema PG, Amin AS, et al. Yield and pitfalls of ajmaline testing in the evaluation of unexplained cardiac arrest and sudden unexplained death.J Am Coll Cardiol EP. 2017; 3:1400–1408. doi: 10.1016/j.jacep.2017.04.005CrossrefGoogle Scholar4. Milman A, Andorin A, Gourraud JB, Sacher F, Mabo P, Kim SH, Maeda S, Takahashi Y, Kamakura T, Aiba T, et al. Age of first arrhythmic event in Brugada syndrome: data from the SABRUS (Survey on Arrhythmic Events in Brugada Syndrome) in 678 patients.Circ Arrhythm Electrophysiol. 2017; 10:e005222. doi: 10.1161/CIRCEP.117.005222LinkGoogle Scholar5. Sieira J, Ciconte G, Conte G, de Asmundis C, Chierchia GB, Baltogiannis G, Di Giovanni G, Saitoh Y, Casado-Arroyo R, Juliá J, et al. Long-term prognosis of drug-induced Brugada syndrome.Heart Rhythm. 2017; 14:1427–1433. doi: 10.1016/j.hrthm.2017.04.044CrossrefMedlineGoogle Scholar eLetters(0) eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate. Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page. Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetails January 2023Vol 16, Issue 1 Advertisement Article Information Metrics © 2023 American Heart Association, Inc.https://doi.org/10.1161/CIRCEP.122.011360PMID: 36595628 Originally publishedJanuary 3, 2023 KeywordsBrugada syndromeelectrocardiographyheart arrestsyncopeventricular fibrillationPDF download Advertisement Subjects Sudden Cardiac Death

Abstract:HomeHypertensionVol. 70, No. 2Expertise: No Longer a Sine Qua Non for Guideline Authors? Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBExpertise: No Longer a Sine Qua Non for Guideline Authors? Franz H. Messerli, Louis Hofstetter, Enrico Agabiti-Rosei, Michel Burnier, William J. Elliott, Stanley S. Franklin, Tomasz Grodzicki, Kazuomi Kario, Sverre E. Kjeldsen, John B. Kostis, Stephane Laurent, Frans H. Leenen, Per Lund-Johansen, Giuseppe Mancia, Krzysztof Narkiewicz, Vasilios Papademetriou, Gianfranco Parati, Neil Poulter, Josep Redon, Stefano F. Rimoldi, Luis M. Ruilope, Ernesto L. Schiffrin, Roland E. Schmieder, Allan B. Schwartz, Peter Sever, James R. Sowers, Jan A. Staessen, Jiguang Wang, Michael Weber and Bryan Williams Franz H. MesserliFranz H. Messerli From the Department of Cardiology and Clinical Research, Inselspital Bern, University of Bern, Switzerland (F.H.M., L.H., S.F.R.); Mount Sinai Icahn School of Medicine, New York, NY (F.H.M.); Jagiellonian University Krakow, Poland (F.H.M.); Department of Clinical and Experimental Sciences, Clinica Medica, University of Brescia, Italy (E.A.R.); Service de Néphrologie et Hypertension, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland (M.B.); Department of Biomedical Sciences, Pacific Northwest University of Health Sciences, Yakima, WA (W.J.E.); Heart Disease Prevention Program, Division of Cardiology, Department of Medicine, C240 Medical Sciences, University of California, Irvine (S.S.F.); Department of Internal Medicine and Gerontology, Jagiellonian University Medical College, Krakow, Poland (T.G.); Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan (K.K.); Department of Cardiology, University of Oslo, Ullevaal Hospital, Norway (S.E.K.); Cardiovascular Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.B.K.); Departments of Pharmacology, European Georges Pompidou Hospital, Assistance Publique Hôpitaux de Paris, Inserm UMR 970, University Paris Descartes, France (S.L.); Hypertension Unit, University of Ottawa Heart Institute, ON, Canada (F.H.L.); Department of Heart Diseases, University of Bergen, Haukeland Hospital, Norway (P.L.-J.); University of Milano-Bicocca, IRCCS Istituto Auxologico Italiano, Italy (G.M.); Department of Hypertension and Diabetology, Medical University of Gdansk, Poland (K.N.); Hypertension and Cardiovascular Research Clinic, Veterans Affairs and Georgetown University Medical Centers, Washington DC (V.P.); Department of Cardiovascular, Neural and Metabolic Sciences, Ospedale S. Luca IRCCS Istituto Auxologico Italiano, Milan; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy (G.P.); Imperial Clinical Trials Unit, Imperial College London, United Kingdom (N.P.); Hospital Clinico Unviersitario de Valencia, Spain (J.R.); Department of Nephrology, Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain (L.M.R.); Lady Davis Institute for Medical Research and Department of Medicine, Jewish General Hospital, McGill University, Montreal, QC, Canada (E.L.S.); Department of Nephrology and Hypertension, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Germany (R.E.S.); Division of Nephrology and Hypertension, Department of Medicine, and American Society of Hypertension, Drexel University College of Medicine, Philadelphia, PA (A.B.S.); International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London-Hammersmith Campus, United Kingdom (P.S.); Diabetes and Cardiovascular Center, University of Missouri School of Medicine, Columbia; Research Service, Harry S. Truman Memorial Veterans Hospital, Research Service, Columbia; Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia (J.R.S.); University of Leuven, Belgium (J.A.S.); Department of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (J.W.); SUNY Downstate Medical Center, Brooklyn, NY (M.W.); and University College London and NIHR University College London Hospitals Biomedical Research Centre, University College London, UK (B.W.). Search for more papers by this author , Louis HofstetterLouis Hofstetter From the Department of Cardiology and Clinical Research, Inselspital Bern, University of Bern, Switzerland (F.H.M., L.H., S.F.R.); Mount Sinai Icahn School of Medicine, New York, NY (F.H.M.); Jagiellonian University Krakow, Poland (F.H.M.); Department of Clinical and Experimental Sciences, Clinica Medica, University of Brescia, Italy (E.A.R.); Service de Néphrologie et Hypertension, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland (M.B.); Department of Biomedical Sciences, Pacific Northwest University of Health Sciences, Yakima, WA (W.J.E.); Heart Disease Prevention Program, Division of Cardiology, Department of Medicine, C240 Medical Sciences, University of California, Irvine (S.S.F.); Department of Internal Medicine and Gerontology, Jagiellonian University Medical College, Krakow, Poland (T.G.); Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan (K.K.); Department of Cardiology, University of Oslo, Ullevaal Hospital, Norway (S.E.K.); Cardiovascular Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.B.K.); Departments of Pharmacology, European Georges Pompidou Hospital, Assistance Publique Hôpitaux de Paris, Inserm UMR 970, University Paris Descartes, France (S.L.); Hypertension Unit, University of Ottawa Heart Institute, ON, Canada (F.H.L.); Department of Heart Diseases, University of Bergen, Haukeland Hospital, Norway (P.L.-J.); University of Milano-Bicocca, IRCCS Istituto Auxologico Italiano, Italy (G.M.); Department of Hypertension and Diabetology, Medical University of Gdansk, Poland (K.N.); Hypertension and Cardiovascular Research Clinic, Veterans Affairs and Georgetown University Medical Centers, Washington DC (V.P.); Department of Cardiovascular, Neural and Metabolic Sciences, Ospedale S. Luca IRCCS Istituto Auxologico Italiano, Milan; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy (G.P.); Imperial Clinical Trials Unit, Imperial College London, United Kingdom (N.P.); Hospital Clinico Unviersitario de Valencia, Spain (J.R.); Department of Nephrology, Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain (L.M.R.); Lady Davis Institute for Medical Research and Department of Medicine, Jewish General Hospital, McGill University, Montreal, QC, Canada (E.L.S.); Department of Nephrology and Hypertension, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Germany (R.E.S.); Division of Nephrology and Hypertension, Department of Medicine, and American Society of Hypertension, Drexel University College of Medicine, Philadelphia, PA (A.B.S.); International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London-Hammersmith Campus, United Kingdom (P.S.); Diabetes and Cardiovascular Center, University of Missouri School of Medicine, Columbia; Research Service, Harry S. Truman Memorial Veterans Hospital, Research Service, Columbia; Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia (J.R.S.); University of Leuven, Belgium (J.A.S.); Department of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (J.W.); SUNY Downstate Medical Center, Brooklyn, NY (M.W.); and University College London and NIHR University College London Hospitals Biomedical Research Centre, University College London, UK (B.W.). Search for more papers by this author , Enrico Agabiti-RoseiEnrico Agabiti-Rosei From the Department of Cardiology and Clinical Research, Inselspital Bern, University of Bern, Switzerland (F.H.M., L.H., S.F.R.); Mount Sinai Icahn School of Medicine, New York, NY (F.H.M.); Jagiellonian University Krakow, Poland (F.H.M.); Department of Clinical and Experimental Sciences, Clinica Medica, University of Brescia, Italy (E.A.R.); Service de Néphrologie et Hypertension, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland (M.B.); Department of Biomedical Sciences, Pacific Northwest University of Health Sciences, Yakima, WA (W.J.E.); Heart Disease Prevention Program, Division of Cardiology, Department of Medicine, C240 Medical Sciences, University of California, Irvine (S.S.F.); Department of Internal Medicine and Gerontology, Jagiellonian University Medical College, Krakow, Poland (T.G.); Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan (K.K.); Department of Cardiology, University of Oslo, Ullevaal Hospital, Norway (S.E.K.); Cardiovascular Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.B.K.); Departments of Pharmacology, European Georges Pompidou Hospital, Assistance Publique Hôpitaux de Paris, Inserm UMR 970, University Paris Descartes, France (S.L.); Hypertension Unit, University of Ottawa Heart Institute, ON, Canada (F.H.L.); Department of Heart Diseases, University of Bergen, Haukeland Hospital, Norway (P.L.-J.); University of Milano-Bicocca, IRCCS Istituto Auxologico Italiano, Italy (G.M.); Department of Hypertension and Diabetology, Medical University of Gdansk, Poland (K.N.); Hypertension and Cardiovascular Research Clinic, Veterans Affairs and Georgetown University Medical Centers, Washington DC (V.P.); Department of Cardiovascular, Neural and Metabolic Sciences, Ospedale S. Luca IRCCS Istituto Auxologico Italiano, Milan; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy (G.P.); Imperial Clinical Trials Unit, Imperial College London, United Kingdom (N.P.); Hospital Clinico Unviersitario de Valencia, Spain (J.R.); Department of Nephrology, Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain (L.M.R.); Lady Davis Institute for Medical Research and Department of Medicine, Jewish General Hospital, McGill University, Montreal, QC, Canada (E.L.S.); Department of Nephrology and Hypertension, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Germany (R.E.S.); Division of Nephrology and Hypertension, Department of Medicine, and American Society of Hypertension, Drexel University College of Medicine, Philadelphia, PA (A.B.S.); International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London-Hammersmith Campus, United Kingdom (P.S.); Diabetes and Cardiovascular Center, University of Missouri School of Medicine, Columbia; Research Service, Harry S. Truman Memorial Veterans Hospital, Research Service, Columbia; Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia (J.R.S.); University of Leuven, Belgium (J.A.S.); Department of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (J.W.); SUNY Downstate Medical Center, Brooklyn, NY (M.W.); and University College London and NIHR University College London Hospitals Biomedical Research Centre, University College London, UK (B.W.). Search for more papers by this author , Michel BurnierMichel Burnier From the Department of Cardiology and Clinical Research, Inselspital Bern, University of Bern, Switzerland (F.H.M., L.H., S.F.R.); Mount Sinai Icahn School of Medicine, New York, NY (F.H.M.); Jagiellonian University Krakow, Poland (F.H.M.); Department of Clinical and Experimental Sciences, Clinica Medica, University of Brescia, Italy (E.A.R.); Service de Néphrologie et Hypertension, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland (M.B.); Department of Biomedical Sciences, Pacific Northwest University of Health Sciences, Yakima, WA (W.J.E.); Heart Disease Prevention Program, Division of Cardiology, Department of Medicine, C240 Medical Sciences, University of California, Irvine (S.S.F.); Department of Internal Medicine and Gerontology, Jagiellonian University Medical College, Krakow, Poland (T.G.); Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan (K.K.); Department of Cardiology, University of Oslo, Ullevaal Hospital, Norway (S.E.K.); Cardiovascular Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.B.K.); Departments of Pharmacology, European Georges Pompidou Hospital, Assistance Publique Hôpitaux de Paris, Inserm UMR 970, University Paris Descartes, France (S.L.); Hypertension Unit, University of Ottawa Heart Institute, ON, Canada (F.H.L.); Department of Heart Diseases, University of Bergen, Haukeland Hospital, Norway (P.L.-J.); University of Milano-Bicocca, IRCCS Istituto Auxologico Italiano, Italy (G.M.); Department of Hypertension and Diabetology, Medical University of Gdansk, Poland (K.N.); Hypertension and Cardiovascular Research Clinic, Veterans Affairs and Georgetown University Medical Centers, Washington DC (V.P.); Department of Cardiovascular, Neural and Metabolic Sciences, Ospedale S. Luca IRCCS Istituto Auxologico Italiano, Milan; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy (G.P.); Imperial Clinical Trials Unit, Imperial College London, United Kingdom (N.P.); Hospital Clinico Unviersitario de Valencia, Spain (J.R.); Department of Nephrology, Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain (L.M.R.); Lady Davis Institute for Medical Research and Department of Medicine, Jewish General Hospital, McGill University, Montreal, QC, Canada (E.L.S.); Department of Nephrology and Hypertension, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Germany (R.E.S.); Division of Nephrology and Hypertension, Department of Medicine, and American Society of Hypertension, Drexel University College of Medicine, Philadelphia, PA (A.B.S.); International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London-Hammersmith Campus, United Kingdom (P.S.); Diabetes and Cardiovascular Center, University of Missouri School of Medicine, Columbia; Research Service, Harry S. Truman Memorial Veterans Hospital, Research Service, Columbia; Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia (J.R.S.); University of Leuven, Belgium (J.A.S.); Department of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (J.W.); SUNY Downstate Medical Center, Brooklyn, NY (M.W.); and University College London and NIHR University College London Hospitals Biomedical Research Centre, University College London, UK (B.W.). Search for more papers by this author , William J. ElliottWilliam J. Elliott From the Department of Cardiology and Clinical Research, Inselspital Bern, University of Bern, Switzerland (F.H.M., L.H., S.F.R.); Mount Sinai Icahn School of Medicine, New York, NY (F.H.M.); Jagiellonian University Krakow, Poland (F.H.M.); Department of Clinical and Experimental Sciences, Clinica Medica, University of Brescia, Italy (E.A.R.); Service de Néphrologie et Hypertension, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland (M.B.); Department of Biomedical Sciences, Pacific Northwest University of Health Sciences, Yakima, WA (W.J.E.); Heart Disease Prevention Program, Division of Cardiology, Department of Medicine, C240 Medical Sciences, University of California, Irvine (S.S.F.); Department of Internal Medicine and Gerontology, Jagiellonian University Medical College, Krakow, Poland (T.G.); Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan (K.K.); Department of Cardiology, University of Oslo, Ullevaal Hospital, Norway (S.E.K.); Cardiovascular Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.B.K.); Departments of Pharmacology, European Georges Pompidou Hospital, Assistance Publique Hôpitaux de Paris, Inserm UMR 970, University Paris Descartes, France (S.L.); Hypertension Unit, University of Ottawa Heart Institute, ON, Canada (F.H.L.); Department of Heart Diseases, University of Bergen, Haukeland Hospital, Norway (P.L.-J.); University of Milano-Bicocca, IRCCS Istituto Auxologico Italiano, Italy (G.M.); Department of Hypertension and Diabetology, Medical University of Gdansk, Poland (K.N.); Hypertension and Cardiovascular Research Clinic, Veterans Affairs and Georgetown University Medical Centers, Washington DC (V.P.); Department of Cardiovascular, Neural and Metabolic Sciences, Ospedale S. Luca IRCCS Istituto Auxologico Italiano, Milan; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy (G.P.); Imperial Clinical Trials Unit, Imperial College London, United Kingdom (N.P.); Hospital Clinico Unviersitario de Valencia, Spain (J.R.); Department of Nephrology, Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain (L.M.R.); Lady Davis Institute for Medical Research and Department of Medicine, Jewish General Hospital, McGill University, Montreal, QC, Canada (E.L.S.); Department of Nephrology and Hypertension, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Germany (R.E.S.); Division of Nephrology and Hypertension, Department of Medicine, and American Society of Hypertension, Drexel University College of Medicine, Philadelphia, PA (A.B.S.); International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London-Hammersmith Campus, United Kingdom (P.S.); Diabetes and Cardiovascular Center, University of Missouri School of Medicine, Columbia; Research Service, Harry S. Truman Memorial Veterans Hospital, Research Service, Columbia; Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia (J.R.S.); University of Leuven, Belgium (J.A.S.); Department of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (J.W.); SUNY Downstate Medical Center, Brooklyn, NY (M.W.); and University College London and NIHR University College London Hospitals Biomedical Research Centre, University College London, UK (B.W.). Search for more papers by this author , Stanley S. FranklinStanley S. Franklin From the Department of Cardiology and Clinical Research, Inselspital Bern, University of Bern, Switzerland (F.H.M., L.H., S.F.R.); Mount Sinai Icahn School of Medicine, New York, NY (F.H.M.); Jagiellonian University Krakow, Poland (F.H.M.); Department of Clinical and Experimental Sciences, Clinica Medica, University of Brescia, Italy (E.A.R.); Service de Néphrologie et Hypertension, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland (M.B.); Department of Biomedical Sciences, Pacific Northwest University of Health Sciences, Yakima, WA (W.J.E.); Heart Disease Prevention Program, Division of Cardiology, Department of Medicine, C240 Medical Sciences, University of California, Irvine (S.S.F.); Department of Internal Medicine and Gerontology, Jagiellonian University Medical College, Krakow, Poland (T.G.); Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan (K.K.); Department of Cardiology, University of Oslo, Ullevaal Hospital, Norway (S.E.K.); Cardiovascular Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.B.K.); Departments of Pharmacology, European Georges Pompidou Hospital, Assistance Publique Hôpitaux de Paris, Inserm UMR 970, University Paris Descartes, France (S.L.); Hypertension Unit, University of Ottawa Heart Institute, ON, Canada (F.H.L.); Department of Heart Diseases, University of Bergen, Haukeland Hospital, Norway (P.L.-J.); University of Milano-Bicocca, IRCCS Istituto Auxologico Italiano, Italy (G.M.); Department of Hypertension and Diabetology, Medical University of Gdansk, Poland (K.N.); Hypertension and Cardiovascular Research Clinic, Veterans Affairs and Georgetown University Medical Centers, Washington DC (V.P.); Department of Cardiovascular, Neural and Metabolic Sciences, Ospedale S. Luca IRCCS Istituto Auxologico Italiano, Milan; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy (G.P.); Imperial Clinical Trials Unit, Imperial College London, United Kingdom (N.P.); Hospital Clinico Unviersitario de Valencia, Spain (J.R.); Department of Nephrology, Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain (L.M.R.); Lady Davis Institute for Medical Research and Department of Medicine, Jewish General Hospital, McGill University, Montreal, QC, Canada (E.L.S.); Department of Nephrology and Hypertension, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Germany (R.E.S.); Division of Nephrology and Hypertension, Department of Medicine, and American Society of Hypertension, Drexel University College of Medicine, Philadelphia, PA (A.B.S.); International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London-Hammersmith Campus, United Kingdom (P.S.); Diabetes and Cardiovascular Center, University of Missouri School of Medicine, Columbia; Research Service, Harry S. Truman Memorial Veterans Hospital, Research Service, Columbia; Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia (J.R.S.); University of Leuven, Belgium (J.A.S.); Department of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (J.W.); SUNY Downstate Medical Center, Brooklyn, NY (M.W.); and University College London and NIHR University College London Hospitals Biomedical Research Centre, University College London, UK (B.W.). Search for more papers by this author , Tomasz GrodzickiTomasz Grodzicki From the Department of Cardiology and Clinical Research, Inselspital Bern, University of Bern, Switzerland (F.H.M., L.H., S.F.R.); Mount Sinai Icahn School of Medicine, New York, NY (F.H.M.); Jagiellonian University Krakow, Poland (F.H.M.); Department of Clinical and Experimental Sciences, Clinica Medica, University of Brescia, Italy (E.A.R.); Service de Néphrologie et Hypertension, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland (M.B.); Department of Biomedical Sciences, Pacific Northwest University of Health Sciences, Yakima, WA (W.J.E.); Heart Disease Prevention Program, Division of Cardiology, Department of Medicine, C240 Medical Sciences, University of California, Irvine (S.S.F.); Department of Internal Medicine and Gerontology, Jagiellonian University Medical College, Krakow, Poland (T.G.); Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan (K.K.); Department of Cardiology, University of Oslo, Ullevaal Hospital, Norway (S.E.K.); Cardiovascular Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.B.K.); Departments of Pharmacology, European Georges Pompidou Hospital, Assistance Publique Hôpitaux de Paris, Inserm UMR 970, University Paris Descartes, France (S.L.); Hypertension Unit, University of Ottawa Heart Institute, ON, Canada (F.H.L.); Department of Heart Diseases, University of Bergen, Haukeland Hospital, Norway (P.L.-J.); University of Milano-Bicocca, IRCCS Istituto Auxologico Italiano, Italy (G.M.); Department of Hypertension and Diabetology, Medical University of Gdansk, Poland (K.N.); Hypertension and Cardiovascular Research Clinic, Veterans Affairs and Georgetown University Medical Centers, Washington DC (V.P.); Department of Cardiovascular, Neural and Metabolic Sciences, Ospedale S. Luca IRCCS Istituto Auxologico Italiano, Milan; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy (G.P.); Imperial Clinical Trials Unit, Imperial College London, United Kingdom (N.P.); Hospital Clinico Unviersitario de Valencia, Spain (J.R.); Department of Nephrology, Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain (L.M.R.); Lady Davis Institute for Medical Research and Department of Medicine, Jewish General Hospital, McGill University, Montreal, QC, Canada (E.L.S.); Department of Nephrology and Hypertension, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Germany (R.E.S.); Division of Nephrology and Hypertension, Department of Medicine, and American Society of Hypertension, Drexel University College of Medicine, Philadelphia, PA (A.B.S.); International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London-Hammersmith Campus, United Kingdom (P.S.); Diabetes and Cardiovascular Center, University of Missouri School of Medicine, Columbia; Research Service, Harry S. Truman Memorial Veterans Hospital, Research Service, Columbia; Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia (J.R.S.); University of Leuven, Belgium (J.A.S.); Department of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (J.W.); SUNY Downstate Medical Center, Brooklyn, NY (M.W.); and University College London and NIHR University College London Hospitals Biomedical Research Centre, University College London, UK (B.W.). Search for more papers by this author , Kazuomi KarioKazuomi Kario From the Department of Cardiology and Clinical Research, Inselspital Bern, University of Bern, Switzerland (F.H.M., L.H., S.F.R.); Mount Sinai Icahn School of Medicine, New York, NY (F.H.M.); Jagiellonian University Krakow, Poland (F.H.M.); Department of Clinical and Experimental Sciences, Clinica Medica, University of Brescia, Italy (E.A.R.); Service de Néphrologie et Hypertension, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland (M.B.); Department of Biomedical Sciences, Pacific Northwest University of Health Sciences, Yakima, WA (W.J.E.); Heart Disease Prevention Program, Division of Cardiology, Department of Medicine, C240 Medical Sciences, University of California, Irvine (S.S.F.); Department of Internal Medicine and Gerontology, Jagiellonian University Medical College, Krakow, Poland (T.G.); Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan (K.K.); Department of Cardiology, University of Oslo, Ullevaal Hospital, Norway (S.E.K.); Cardiovascular Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.B.K.); Departments of Pharmacology, European Georges Pompidou Hospital, Assistance Publique Hôpitaux de Paris, Inserm UMR 970, University Paris Descartes, France (S.L.); Hypertension Unit, University of Ottawa Heart Institute, ON, Canada (F.H.L.); Department of Heart Diseases, University of Bergen, Haukeland Hospital, Norway (P.L.-J.); University of Milano-Bicocca, IRCCS Istituto Auxologico Italiano, Italy (G.M.); Department of Hypertension and Diabetology, Medical University of Gdansk, Poland (K.N.); Hypertension and Cardiovascular Research Clinic, Veterans Affairs and Georgetown University Medical Centers, Washington DC (V.P.); Department of Cardiovascular, Neural and Metabolic Sciences, Ospedale S. Luca IRCCS Istituto Auxologico Italiano, Milan; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy (G.P.); Imperial Clinical Trials Unit, Imperial College London, United Kingdom (N.P.); Hospital Clinico Unviersitario de Valencia, Spain (J.R.); Department of Nephrology, Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain (L.M.R.); Lady Davis Institute for Medical Research and Department of Medicine, Jewish General Hospital, McGill University, Montreal, QC, Canada (E.L.S.); Department of Nephrology and Hypertension, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Germany (R.E.S.); Division of Nephrology and Hypertension, Department of Medicine, and American Society of Hypertension, Drexel University College of Medicine, Philadelphia, PA (A.B.S.); International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London-Hammersmith Campus, United Kingdom (P.S.); Diabetes and Cardiovascular Center, University of Missouri School of Medicine, Columbia; Research Service, Harry S. Truman Memorial Veterans Hospital, Research Service, Columbia; Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia (J.R.S.); University of Leuven, Belgium (J.A.S.); Department of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (J.W.); SUNY Downstate Medical Center, Brooklyn, NY (M.W.); and University College London and NIHR University College London Hospitals Biomedical Research Centre, University College London, UK (B.W.). Search for more papers by this author , Sverre E. KjeldsenSverre E. Kjeldsen From the Department of Cardiology and Clinical Research, Inselspital Bern, University of Bern, Switzerland (F.H.M., L.H., S.F.R.); Mount Sinai Icahn School of Medicine, New York, NY (F.H.M.); Jagiellonian University Krakow, Poland (F.H.M.); Department of Clinical and Experimental Sciences, Clinica Medica, University of Brescia, Italy (E.A.R.); Service de Néphrologie et Hypertension, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland (M.B.); Department of Biomedical Sciences, Pacific Northwest University of Health Sciences, Yakima, WA (W.J.E.); Heart Disease Prevention Program, Division of Cardiology, Department of Medicine, C240 Medical Sciences, University of California, Irvine (S.S.F.); Department of Internal Medicine and Gerontology, Jagiel

Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders

Characteristics of Patients with Spontaneous Versus Drug-Induced Brugada Electrocardiogram: Sub-Analysis from the SABRUS

Risk of celiac disease autoimmunity is modified by interactions between CD247 and environmental exposures

Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide survey

Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort

Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Scleritis

Referrals for rheumatologic evaluation following a positive antinuclear antibody test result. A cross-sectional single center Brazilian study

Efficacy of Rituximab for Patients with Anti-Glomerular Basement Membrane Disease.

Expertise: No Longer a Sine Qua Non for Guideline Authors?

Proceedings of the 2016 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Scientific Meeting : Toronto, Canada. 14-17 April 2016

GWAS defines pathogenic signaling pathways and prioritizes drug targets for IgA nephropathy

Reggio Emilia (Northern Italy) Interdisciplinary Uveitis Clinic: What We Have Learned in the Last 20 Years

Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study – IL PSO (Italian landscape psoriasis)

Ocular involvement in adult and paediatric patients with monogenic autoinflammatory diseases: a Spanish multicentre retrospective study

The role of centre and country factors on process and outcome indicators in critically ill patients with hospital-acquired bloodstream infections

Insights From a Large-Scale Whole-Genome Sequencing Study of Systolic Blood Pressure, Diastolic Blood Pressure, and Hypertension

Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis.

Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study

Risk of autoimmune diseases in patients with RASopathies: systematic study of humoral and cellular immunity

AB0511 INTERNATIONAL CONSENSUS ON ANCA TESTING AND INTERPRETATION BEYOND SYSTEMIC VASCULITIS

Ocular microvascular damage in autoimmune rheumatic diseases: The pathophysiological role of the immune system